Dr. Kate Broderick is the Chief Innovation Officer at Maravai LifeSciences, leading their Office of Science and Innovation. Dr. Broderick has a broad background in product development in the DNA therapeutic and drug delivery field. Prior to joining Maravai in 2022, Dr. Broderick spent 15 years at Inovio Pharmaceuticals, and has served as a principal investigator for a variety of grants and awards from government agencies and non-profits, including the National Institutes of Health. She received her PhD from the University of Glasgow in Scotland and completed her post-doctoral research at the University of California, San Diego.